Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma
- 17 June 2010
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 28 (4) , 1475-1480
Abstract
Radical surgery is not feasible for all osteosarcoma patients. Overall survival for non-extremity osteosarcoma, as well as for patients with metastatic disease at diagnosis remains poor. For such patients, radical radiotherapy combined with chemotherapy may present an effective treatment approach. This report describes the results of conservative treatment for osteosarcoma patients not suitable for surgery. Seven out of 71 consecutive osteosarcoma patients were treated non-surgically at the Helsinki University Central Hospital either due to the inoperability of the tumour or the patient’s choice of therapy. Staging procedures and measurement of tumour size were performed using computed tomography and magnetic resonance imaging. Six patients were treated with chemo-radiotherapy, and one patient received radiotherapy alone. Five patients received computer-assisted dose-planned radiotherapy with curative intent (total dose 60–70.5 Gray), and two patients received radiotherapy as palliation. Radiotherapy relieved symptoms efficiently. Median time to local failure was 2.6 years (range 0.5–16.9+ years). Five year after treatment termination four patients were alive, and one of them remained disease-free. For selected patients not suitable for surgery, radiotherapy combined with chemotherapy provides an option to reduce symptoms caused by the primary tumour and improve quality of life. For some patients, this approach may (even) produce long-term remission.Keywords
This publication has 16 references indexed in Scilit:
- Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcomaEuropean Journal of Cancer, 2009
- Multimodality treatment of osteosarcoma: Radiation in a high‐risk cohortPediatric Blood & Cancer, 2008
- Radiotherapy for local control of osteosarcomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamideAnnals of Oncology, 2003
- Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group ProtocolsJournal of Clinical Oncology, 2003
- Scandinavian Sarcoma Group Osteosarcoma Study SSG VIIIEuropean Journal of Cancer, 2003
- Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the ExtremitiesMayo Clinic Proceedings, 2003
- Neoadjuvant chemotherapy for osteosarcoma of the extremityEuropean Journal of Cancer, 2001
- Postoperative radiotherapy in the management of adult soft tissue sarcoma of the extremities: results with two different total dose, fractionation, and overall treatment time schedulesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- The treatment of osteosarcoma: Present trendsAnnals of Oncology, 1992